image
Mineralys Therapeutics, Inc. MLYS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 11.48
-5.67 %
$ 571 M
Market Cap
-4.16
P/E
BALANCE SHEET
252 M ASSETS
119.88%
Growth Rates
1Year 119.88%
3Years 453.25%
5Years 0.00%
7Years 0.00%
10Years 0.00%
10.5 M LIABILITIES
-93.71%
Growth Rates
1Year -93.71%
3Years 27.28%
5Years 0.00%
7Years 0.00%
10Years 0.00%
241 M EQUITY
561.37%
Growth Rates
1Year 561.37%
3Years 310.24%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Mineralys Therapeutics, Inc.
image
Current Assets 249 M
Cash & Short-Term Investments 237 M
Receivables 0
Other Current Assets 12.5 M
Non-Current Assets 2.53 M
Long-Term Investments 2.48 M
PP&E 0
Other Non-Current Assets 51 K
Current Liabilities 10.5 M
Accounts Payable 601 K
Short-Term Debt 0
Other Current Liabilities 9.88 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 49.3 87.7 10.6 1.4
Short Term Investments 187.3 22.4 0 0
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 12.5 2.7 0.5 57 K
Total Current Assets 249.1 110.1 11.1 1.5
PP&E 0 0 0 0
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 2.5 0 0 0
Other Long Term Assets 51 K 4.3 3 K 20 K
Other Assets 0 0 0 0
Total Assets 251.6 114.4 11.1 1.5
LIABILITIES
Accounts Payable 0.6 1.9 0.8 0.5
Short Term Debt 0 0 0 4.5
Other Current Liabilities 9.9 6.2 4.3 54 K
Total Current Liabilities 10.5 8.1 5.1 5.1
Long Term Debt 0 0 0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 0 0 0 0
Total Liabilities 10.5 166.7 34.0 5.1
EQUITY
Common Stock 4 K 1 K 1 K 1 K
Retained Earnings (124.7) (52.8) (23.0) (3.6)
Other Accumulative Comprehensive Income/Loss 0 (158.6) 0 0
Total Equity 241.2 (52.3) (22.9) (3.6)
Total Liabilities and Equity 251.6 114.4 11.1 1.5
SHARES OUTSTANDING
Common Shares Outstanding 36.2 40.9 39.1 39.1